Activity in this selectionmain-sequence-eddca6bf
- Rounds participated in
- 1
- Confirmed lead rounds
- —
1 roles undisclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $29M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionGaluxDevelops AI-driven protein design platform for de novo antibody and drug discovery
Role not disclosed